Skip to Main text

About Us

About Us

The Nitto Group strives to become a centennial company that is always trusted by customers, embraced by employees with pride, makes an active contribution to society, and continuously grows on a global scale.

What's New RSS

The Nitto website is currently under system maintenance. Please try again later.
2016/Nov/11 Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
2016/Nov/02 Initiation of Phase I Clinical Trial for Seasonal Influenza HA Vaccine Sublingual Tablet
2016/Oct/12 Nitto Denko Avecia Inc. Acquires Assets of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals

Back to Page Top